Clinical Trial

Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis

Study acronym: PRECISE DM DX
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 8, 2025 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to learn why some adults over the age of 65, have A1c tests that do not match up with their blood glucose levels, also known as 'A1c-glucose discordance'. The main question it aims to answer is: Could alternative tests like CGM or personalized A1c provide more accurate diabetes screening in this population? Participants will be asked to perform blood tests every week to two weeks and wear a CGM for up to 8 weeks.
Trial Details
NCT Number NCT07111416
Lead Sponsor Brigham and Women's Hospital
Collaborators: Abbott Diabetes Care
Conditions Type 2 Diabetes
Enrollment 45 participants
Start Date 2025-09-01
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-08